✦ LIBER ✦

Factors predictive of toxicity associated with bevacizumab and chemotherapy in recurrent ovarian cancer: A multi-institutional study

✍ Scribed by J. Chan; W. Huh; C. McClung; A. Alvarez-Secord; K. Moore; R. Previs; L. Perry; K. Fuh; J. Chapman; T. Tillmanns

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic factors predictive of respons

✍ A. Alvarez-Secord; W. Huh; T. Tillmanns; K. Moore; J. Chapman; C. McClung; T. Ki 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 86 KB

A multi-institutional evaluation of fact

✍ J.D. WRIGHT; A.A. SECORD; T.M. NUMNUM; R.P. ROCCONI; M.A. POWELL; A. BERCHUCK; R 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB

The efficacy and safety of chemotherapy

✍ K. Fuh; A. Alvarez-Secord; W. Huh; T. Tillmanns; K. Moore; K. Bevis; A. ElNaggar 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Outcomes of ovarian cancer patients afte

✍ J. Chan; A. Alvarez-Secord; T. Tillmanns; K. Moore; K. Bevis; A. ElNaggar; L. Pe 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Determining surrogate endpoints predicti

✍ S. Ueda; A. Alvarez-Secord; W. Huh; T. Tillmanns; K. Moore; R. Previs; L. Perry; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Trends of bevacizumab use and toxicity i

✍ J. Chapman; K. Fuh; A. Alvarez-Secord; W. Huh; T. Tillmanns; K. Moore; K. Bevis; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 64 KB